🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and tolerability of Ico...
Status
Completed
Location
West China Hospital
Start Date
2011-12
Trial ID
NCT01516983
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of icotini...
Status
Unknown
Location
Baotou Central Hospital
Start Date
2013-06
Trial ID
NCT01926171
Treatments Being Tested
EGFR-TKI is good for the patients with EGFR-mutant non-small cell lung canc...
Status
Completed
Location
Guangdong General Hospital
Start Date
2012-10-14
Trial ID
NCT01724801
Treatments Being Tested
The aim of this study is to explore the efficacy and toxicity of icotinib c...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2012-01
Trial ID
NCT01514877
Treatments Being Tested
This is a multi-center phase III randomized controlled study, designing to ...
Status
Unknown
Location
Sun Yat-sen University of cancer center
Start Date
2015-08
Trial ID
NCT02714010
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of icotinib alone or ...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2018-07-20
Trial ID
NCT04058704
Treatments Being Tested
A multi-center phase III randomized controlled study to evaluate the effica...
Status
Unknown
Location
Sichuan PPH, Cancer Center
Start Date
2015-03
Trial ID
NCT02882984
The purpose of this study is to evaluate the efficacy of icotinib in combin...
Status
Unknown
Location
Multiple Locations
Start Date
2018-12-01
Trial ID
NCT03754530
Treatments Being Tested